Improving follow-up care for inherited cancer testing
IMProving Care After Inherited Cancer Testing (IMPACT) Study
['FUNDING_U01'] · VANDERBILT UNIVERSITY MEDICAL CENTER · NIH-10914229
This study is looking to improve the follow-up care for people who have had genetic testing for inherited cancer, helping them and their families understand their results better and manage their cancer risks more effectively.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | VANDERBILT UNIVERSITY MEDICAL CENTER (nih funded) |
| Locations | 1 site (NASHVILLE, UNITED STATES) |
| Trial ID | NIH-10914229 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the follow-up care for individuals who have undergone genetic testing for inherited cancer. It aims to address the gaps in care that lead to both over-treatment and under-treatment of patients with specific genetic variants. By implementing two innovative interventions, the study seeks to improve cancer risk management and facilitate better communication of genetic test results among family members. The research will involve a diverse group of 600 participants to evaluate the effectiveness of these interventions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have received genetic testing results indicating pathogenic or likely pathogenic variants related to inherited cancer.
Not a fit: Patients who do not have a family history of cancer or have not undergone genetic testing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective management of cancer risk for individuals with inherited genetic variants and better communication of these risks within families.
How similar studies have performed: Other research has shown success in improving follow-up care and communication regarding genetic testing, making this approach both relevant and promising.
Where this research is happening
NASHVILLE, UNITED STATES
- VANDERBILT UNIVERSITY MEDICAL CENTER — NASHVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PAL, TUYA — VANDERBILT UNIVERSITY MEDICAL CENTER
- Study coordinator: PAL, TUYA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Genes, Cancer Treatment, Cancer-Promoting Gene